Contrast the biochemical and pharmacological properties and clinical applications of new and emerging BTKi for mantle cell lymphoma (MCL) Evaluate recent clinical data incorporating BTKi in frontline therapy for MCL Determine how BTKi toxicities will impact therapy selection Create protocols for appropriate safety monitoring and adverse event management for veterans receiving BTKi i
- Provider:Medical Education Resources
- Activity Link: https://mycme.com
- Start Date: 2024-11-08 06:00:00
- End Date: 2024-11-08 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: AstraZeneca (Any division) - Amount: 45000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest